Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 208

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Future cancer research priorities in the USA: a Lancet Oncology Commission

Open access
Jaffee, Elizabeth M, Dang, Chi Van, Agus, David B, Alexander, Brian M, Anderson, Kenneth C, Ashworth, Alan, Barker, Anna D, Bastani, Roshan, Bhatia, Sangeeta, Bluestone, Jeffrey A, Brawley, Otis, Butte, Atul J, Coit, Daniel G, Davidson, Nancy E, Davis, Mark, DePinho, Ronald A, Diasio, Robert B, Draetta, Giulio, Frazier, A Lindsay, Futreal, Andrew, Gambhir, Sam S, Ganz, Patricia A, Garraway, Levi, Gerson, Stanton, Gupta, Sumit, Heath, James, Hoffman, Ruth I, Hudis, Cliff, Hughes-Halbert, Chanita, Ibrahim, Ramy, Jadvar, Hossein, Kavanagh, Brian, Kittles, Rick, Le, Quynh-Thu, Lippman, Scott M, Mankoff, David, Mardis, Elaine R, Mayer, Deborah K, McMasters, Kelly, Meropol, Neal J, Mitchell, Beverly, Naredi, Peter, Ornish, Dean, Pawlik, Timothy M, Peppercorn, Jeffrey, Pomper, Martin G, Raghavan, Derek, Ritchie, Christine, Schwarz, Sally W, Sullivan, Richard, Wahl, Richard, Wolchok, Jedd D, Wong, Sandra L, Yung, Alfred · 2017 · The Lancet Oncology

Abstract

We are in the midst of a technological revolution that is providing new insights into human biology and cancer. In this era of big data, we are amassing large amounts of information that is transforming how we approach cancer treatment and prevention. Enactment of the Cancer Moonshot within the 21st Century Cures Act in the USA arrived at a propitious moment in the advancement of knowledge, providing nearly US$2 billion of funding for cancer research and precision medicine. In 2016, the Blue Ribbon Panel (BRP) set out a roadmap of recommendations designed to exploit new advances in cancer diagnosis, prevention, and treatment. Those recommendations provided a high-level view of how to accelerate the conversion of new scientific discoveries into effective treatments and prevention for cancer. The US National Cancer Institute is already implementing some of those recommendations. As experts in the priority areas identified by the BRP, we bolster those recommendations to implement this important scientific roadmap. In this Commission, we examine the BRP recommendations in greater detail and expand the discussion to include additional priority areas, including surgical oncology, radiation oncology, imaging, health systems and health disparities, regulation and financing, population science, and oncopolicy. We prioritise areas of research in the USA that we believe would accelerate efforts to benefit patients with cancer. Finally, we hope the recommendations in this report will facilitate new international collaborations to further enhance global efforts in cancer control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(17)30698-8

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 208

Metadata

Authors
Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S., Bluestone, J. A., Brawley, O., Butte, A. J., Coit, D. G., Davidson, N. E., Davis, M., DePinho, R. A., Diasio, R. B., Draetta, G., Frazier, A. L., Futreal, A., Gambhir, S. S., Ganz, P. A., Garraway, L., Gerson, S., Gupta, S., Heath, J., Hoffman, R. I., Hudis, C., Hughes-Halbert, C., Ibrahim, R., Jadvar, H., Kavanagh, B., Kittles, R., Le, Q.-T., Lippman, S. M., Mankoff, D., Mardis, E. R., Mayer, D. K., McMasters, K., Meropol, N. J., Mitchell, B., Naredi, P., Ornish, D., Pawlik, T. M., Peppercorn, J., Pomper, M. G., Raghavan, D., Ritchie, C., Schwarz, S. W., Sullivan, R., Wahl, R., Wolchok, J. D., Wong, S. L., & Yung, A.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2017-11
Volume
18
Issue
11
Pages
e653-e706
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2766668723
Cited by
208
References
58
FWCI
22.16
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Future cancer research priorities in the USA: a Lancet Oncology Commission. https://app.cochat.ai/papers/10.1016/s1470-2045(17)30698-8
The paper
Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S., Bluestone, J. A., Brawley, O., Butte, A. J., Coit, D. G., Davidson, N. E., Davis, M., DePinho, R. A., Diasio, R. B., Draetta, G., Frazier, A. L., . . . Yung, A. (2017). Future cancer research priorities in the USA: a Lancet Oncology Commission. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(17)30698-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.